UBS upgrades Scotts Miracle-Gro stock as target falls to USD 70.00

Published on 10/20/2026 at 13:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Third-quarter adjusted earnings per share reached USD 2.82 versus USD 2.48 expected. Scotts Miracle-Gro stock costs EUR 48.54 on October 20, 2026.

Analyst view and reporting date

UBS moved its rating to Buy and set a USD 70.00 target on October 15, 2026.
UBS projected fiscal 2027 organic revenue growth of 2.20 percent against consensus of 1.60 percent.
Scotts Miracle-Gro stock was trading at EUR 48.54 at 1:28 p.m. CEST at Lang & Schwarz on October 20, 2026.
The next earnings conference call is scheduled for November 4, 2026.

SMG, US8101861065, Illustration mit AI erstellt.

Scotts Miracle-Gro stock is trading at EUR 48.54 at Lang & Schwarz on October 20, 2026, while UBS moved its rating to Buy from Neutral and cut its target from USD 78.00 to USD 70.00 on October 15, 2026. According to Markets Insider, analyst Peter Grom cited valuation and a path to earnings growth through fiscal 2027.

The target cut changes the signal

The rating upgrade came with a lower target, making the valuation argument more important than a simple bullish call. UBS said the stock had underperformed since the analyst day in early August and that inflationary pressure remained a risk. The firm nevertheless sees a route to earnings growth through productivity and product mix.

TradingView reported that UBS projected fiscal 2027 organic revenue growth of 2.20 percent against consensus of 1.60 percent. Its adjusted earnings per share forecast was USD 4.76 versus USD 4.70 consensus for fiscal 2027.

What supports the upgrade case?

The operating evidence came from the quarter ended June 27, 2026. Scotts Miracle-Gro reported adjusted earnings per share of USD 2.82 against an estimate of USD 2.5148, a 12.14 percent surprise, while revenue reached USD 1.1721 billion against an estimate of USD 1.1843 billion, according to Nasdaq. The earnings comparison supports the focus on execution, but revenue was below the estimate.

Upcoming reporting date

The next substantiated company date is November 4, 2026, when Scotts Miracle-Gro is scheduled to hold its fiscal 2026 fourth-quarter earnings conference call. The date appears in the company investor-relations calendar at The Scotts Miracle-Gro Company.

Price remains the market anchor

The company is listed as NYSE:SMG in the Nasdaq report, while the German-market indication gives investors a euro reference for the current session. At 1:28 p.m. CEST, the stock was trading at EUR 48.54 at Lang & Schwarz on October 20, 2026.

The further course of trading is shown by the continuously updated real-time quote of Scotts Miracle-Gro stock.